Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

60.98
Delayed Data
As of Sep 02
 +0.48 / +0.79%
Today’s Change
52.06
Today|||52-Week Range
71.60
-6.82%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Operating ActivitiesNet Income / Starting Line3.4B5.3B4.1B1.8B
 
 
 
 
 
Depreciation1.3B1.2B897.0M786.0M
 
 
 
 
 
Total Other Cash Flow835.5M541.0M584.0M1.8B
 
 
 
 
 
Funds From Operations5.5B7.0B5.6B4.3B
 
 
 
 
 
Funds From/For Other Operating Expenses-706.2M621.0M-658.0M788.0M
 
 
 
 
 
Net Cash Flow - Operating Activities6.2B6.3B6.3B3.5B
 
 
 
 
 
 
InvestingIncrease In Investments-1.9B-2.6B-930.0M-1.2B
 
 
 
 
 
Decrease In Investments1.3B1.2B2.7B1.5B
 
 
 
 
 
Capital Expenditures-355.5M-333.0M-491.0M-612.0M
 
 
 
 
 
Net Assets From Acquisitions -272.5M-688.0M-405.0M-622.0M
 
 
 
 
 
Other Investing - Sources1.9B0.000.000.00
 
 
Net Cash Flow Investing553.9M-2.4B879.0M-926.0M
 
 
 
 
 
 
FinancingShort Term Borrowings0.001.0B-601.0M12.0M
 
 
 
 
Long Term Borrowings0.0014.6B0.000.00
 
 
Long Term Debt Reduction-21.1M0.000.000.00
 
 
Net Proceeds Stock Sale0.000.00347.0M225.0M
 
 
 
Common Preferred Redeemed0.000.00-320.0M-652.0M
 
 
 
Common Dividends0.000.00-2.6B-2.7B
 
 
 
Cash Dividends Paid - Total0.000.00-2.6B-2.7B
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing6.8B13.7B313.0M217.0M
 
 
 
 
 
Net Cash Flow - Financing-6.8B1.9B-3.4B-3.3B
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash--16.0M-10.0M-577.0M
 
 
 
 
 
Net Change In Cash17.8M5.9B3.7B-670.0M